Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
Georg Jeryczynski(Medical University of Vienna), Heinz Gisslinger(Medical University of Vienna), Thamer Sliwa(Hanusch Hospital), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Martin Schalling(Karolinska University Hospital), Albert Wölfler(Medical University of Graz), Andreas Gleiß(Medical University of Vienna), Bettina Gisslinger(Medical University of Vienna), Klaus Geißler(University of Vienna), Maria‐Theresa Krauth(Medical University of Vienna), Alexander Nader(Hanusch Hospital), Christine Beham‐Schmid(Medical University of Graz), Ernst Schlögl(Hanusch Hospital), Michael Vesely(Klinik Hietzing), Ingrid Simonitsch‐Klupp(Medical University of Vienna), Sonja Burgstaller(Klinikum Wels-Grieskirchen), Jürgen Thiele, Leonhard Müllauer(Hochschule Campus Wien)
Cited by 66
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450